Australia markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
113.66+0.18 (+0.16%)
At close: 04:00PM EDT
113.50 -0.16 (-0.14%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 197.22B
Enterprise value 205.57B
Trailing P/E 34.87
Forward P/E 24.63
PEG ratio (5-yr expected) 6.24
Price/sales (ttm)4.96
Price/book (mrq)5.11
Enterprise value/revenue 5.13
Enterprise value/EBITDA 19.50

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 312.25%
S&P500 52-week change 327.86%
52-week high 3121.64
52-week low 389.67
50-day moving average 3115.14
200-day moving average 3106.45

Share statistics

Avg vol (3-month) 35.75M
Avg vol (10-day) 39.43M
Shares outstanding 51.74B
Implied shares outstanding 61.74B
Float 81.72B
% held by insiders 10.54%
% held by institutions 177.05%
Shares short (15 Mar 2024) 415.72M
Short ratio (15 Mar 2024) 42.92
Short % of float (15 Mar 2024) 40.91%
Short % of shares outstanding (15 Mar 2024) 40.91%
Shares short (prior month 15 Feb 2024) 414.29M

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 41.94%
Trailing annual dividend rate 32.08
Trailing annual dividend yield 31.83%
5-year average dividend yield 41.59
Payout ratio 462.58%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 210000:4798
Last split date 302 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 14.27%
Operating margin (ttm)20.09%

Management effectiveness

Return on assets (ttm)6.11%
Return on equity (ttm)15.11%

Income statement

Revenue (ttm)40.11B
Revenue per share (ttm)23.05
Quarterly revenue growth (yoy)1.50%
Gross profit (ttm)N/A
EBITDA 10.46B
Net income avi to common (ttm)5.7B
Diluted EPS (ttm)3.26
Quarterly earnings growth (yoy)54.30%

Balance sheet

Total cash (mrq)7.28B
Total cash per share (mrq)4.2
Total debt (mrq)15.87B
Total debt/equity (mrq)40.88%
Current ratio (mrq)1.64
Book value per share (mrq)22.26

Cash flow statement

Operating cash flow (ttm)7.26B
Levered free cash flow (ttm)4.99B